Invention Grant
- Patent Title: Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
-
Application No.: US15272283Application Date: 2016-09-21
-
Publication No.: US10240207B2Publication Date: 2019-03-26
- Inventor: Wei Yu , David Shames , Hartmut Koeppen , See Phan , Sandra Rost
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; C07K16/22 ; C07K16/28 ; A61K39/00
Abstract:
The present invention concerns cancer biomarkers. In particular, the invention concerns HGF as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
Public/Granted literature
- US20170183740A1 CANCER TREATMENT WITH C-MET ANTAGONISTS AND CORRELATION OF THE LATTER WITH HGF EXPRESSION Public/Granted day:2017-06-29
Information query
IPC分类:
